Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 242

    1.

    Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia.

    Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, Ahmadi R, Nawaz H.

    Diabetes Care. 2003 Apr;26(4):1064-8.PMID: 12663574 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Usefulness of stable HbA(1c) for supportive marker to diagnose diabetes mellitus in Japanese subjects.

    Tanaka Y, Atsumi Y, Matsuoka K, Mokubo A, Asahina T, Hosokawa K, Shimada S, Matsunaga H, Takagi M, Ogawa O, Onuma T, Kawamori R.

    Diabetes Res Clin Pract. 2001 Jul;53(1):41-5.PMID: 11378212 [PubMed - indexed for MEDLINE]Related articles

    3.

    Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.

    Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A.

    Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.PMID: 17919531 [PubMed - indexed for MEDLINE]Related articles

    5.

    Is fasting blood glucose a reliable parameter for screening for diabetes in hypertension?

    Bur A, Herkner H, Woisetschläger C, Vlcek M, Derhaschnig U, Hirschl MM.

    Am J Hypertens. 2003 Apr;16(4):297-301.PMID: 12670746 [PubMed - indexed for MEDLINE]Related articles

    6.

    Projected impact of implementing the results of the diabetes prevention program in the U.S. population.

    Saydah SH, Byrd-Holt D, Harris MI.

    Diabetes Care. 2002 Nov;25(11):1940-5.PMID: 12401736 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.

    Jesudason DR, Dunstan K, Leong D, Wittert GA.

    Diabetes Care. 2003 Feb;26(2):485-90.PMID: 12547886 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The relationship of plasma glucose and HbA1c Levels among emergency department patients with no prior history of diabetes mellitus.

    Silverman RA, Pahk R, Carbone M, Wells E, Mitzner R, Burris K, Kelson JR, Grella R, Katzeff H.

    Acad Emerg Med. 2006 Jul;13(7):722-6. Epub 2006 May 2.PMID: 16670260 [PubMed - indexed for MEDLINE]Related articles

    11.

    Haemoglobin A(1c) measurement for diabetes among subjects with a previous history of impaired glucose tolerance.

    Qiao Q, Keinänen-Kukaanniemi, Kivelä SL.

    Diabetes Res Clin Pract. 1995 Dec;30(3):189-94.PMID: 8861458 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prognostic value of admission plasma glucose and HbA in acute myocardial infarction.

    Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, Torremocha F, Herpin D, Marechaud R.

    Diabet Med. 2004 Apr;21(4):305-10.PMID: 15049930 [PubMed - indexed for MEDLINE]Related articles

    13.

    Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects.

    Kim KS, Kim SK, Lee YK, Park SW, Cho YW.

    Diabet Med. 2008 Aug;25(8):997-1000.PMID: 18959616 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prevalence of diabetes estimated by plasma glucose criteria combined with standardized measurement of HbA1c among health checkup participants on Miyako Island, Japan.

    Takahashi Y, Noda M, Tsugane S, Kuzuya T, Ito C, Kadowaki T.

    Diabetes Care. 2000 Aug;23(8):1092-6.PMID: 10937503 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.

    Bonora E, Calcaterra F, Lombardi S, Bonfante N, Formentini G, Bonadonna RC, Muggeo M.

    Diabetes Care. 2001 Dec;24(12):2023-9.PMID: 11723077 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Utility of casual postprandial glucose levels in type 2 diabetes management.

    El-Kebbi IM, Ziemer DC, Cook CB, Gallina DL, Barnes CS, Phillips LS.

    Diabetes Care. 2004 Feb;27(2):335-9.PMID: 14747210 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.

    Bennett CM, Guo M, Dharmage SC.

    Diabet Med. 2007 Apr;24(4):333-43. Epub 2007 Mar 15. Review. Erratum in: Diabet Med. 2007 Sep;24(9):1054. PMID: 17367307 [PubMed - indexed for MEDLINE]Related articles

    18.

    Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations.

    Manley SE, Sikaris KA, Lu ZX, Nightingale PG, Stratton IM, Round RA, Baskar V, Gough SC, Smith JM.

    Diabet Med. 2009 Feb;26(2):115-21.PMID: 19236612 [PubMed - indexed for MEDLINE]Related articles

    19.

    Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial.

    Morrow DA, Scirica BM, Chaitman BR, McGuire DK, Murphy SA, Karwatowska-Prokopczuk E, McCabe CH, Braunwald E; MERLIN-TIMI 36 Investigators.

    Circulation. 2009 Apr 21;119(15):2032-9. Epub 2009 Apr 6.PMID: 19349325 [PubMed - indexed for MEDLINE]Related articles

    20.

    HbA1c screening for undiagnosed diabetes in New Zealand.

    Ellison TL, Elliott R, Moyes SA.

    Diabetes Metab Res Rev. 2005 Jan-Feb;21(1):65-70.PMID: 15386815 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data